
Yevgeniy Brailovsky DO MSc FACC
@yevgeniybr
Heart Failure, Heart Transplant, and Amyloidosis Cardiologist
ID: 212491433
06-11-2010 06:37:58
4,4K Tweet
2,2K Followers
2,2K Following




Impressive results. Looking forward to phase 3 study! American College of Cardiology #ACC25

Listen in for a 1.5 minute summary on AltShock-2 trial for American College of Cardiology on ACC Everywhere. Many thanks to American College of Cardiology ISLC for the opportunity! #ACC2025 The Warren Alpert Medical School Brown University Health


Fabulous schematic of the RV failure spiral in pulmonary embolism explaining the generation of laboratory and #POCUS findings as things increasingly go to shit Thanks NephroPOCUS for finding this 👊 from link.springer.com/article/10.100…



🔴 Changing Treatment Landscape in Transthyretin Cardiac Amyloidosis Circulation #Cardiology #cardioEd #Amyloidosis #FOAMed


Please share this exciting and interactive Amyloid case based seminar w/your fellow Amyloid champions and trainees. Brett Sperry, MD Mazen Hanna Melissa Lyle Martha Grogan MD Ahmad Masri Yevgeniy Brailovsky DO MSc FACC Michelle Kittleson MD PhD Ronald Witteles Rafael Fonseca MD 🦔🇺🇸🏜🇲🇽 Kevin Alexander

We share updates on Definition, Diagnosis and Treatment Strategies for submassive and massive PE. Work led by Brian Choi Youssef Elfatatry Amir Darki MD, MSc Loyola Medicine's PERT Team JeffPERT PERT Consortium authors.elsevier.com/a/1k-yp_bQgbuP0


Congratulations Yevgeniy Brailovsky DO MSc FACC on leading this important effort and contributing to the literature in this challenging diagnostic dilemmas. Great job as well Brian Choi and Youssef Elfatatry

Unplanned admissions for WHF are the costliest part of care. This review explores how invasive & non-invasive pressure sensing—aided by AI—can personalize treatment, detect congestion earlier, and prevent decompensation (link.springer.com/article/10.100…). #HREV Anu Lala-Trindade Andrew J Sauer MD



Thread/ Very excited to see our RESCUE-II study in print JACC Journals Advances. In this study we evaluated bolus-only r-tPA w/o infusion for management of acute intermediate-risk PE. #CardioTwitter #ACCFIT sciencedirect.com/science/articl…


The passing of a legendary figure in the quest for the perfect artificial heart. Rest in peace, Dr Jarvik - nytimes.com/2025/05/29/sci… Bernard Kadosh Alex Reyentovich, MD JCF Intersections Society Of Critical Care Cardiology

Excellent study in JACC Journals focusing on I-124 evuzamitide in patients with "early" transthyretin amyloidosis ( having negative or quivocal bone scintigraphy (PYP)). Excellent performance of evuzamitide in this cohort. jacc.org/doi/10.1016/j.… #CardioTwitter


Everything you want to know about belatacept therapy in heart transplant recipients Our experience now in JHLT ColumbiaCardiology Excellent work from ⭐️ fellow Dr. Julia Baranowska! Gabriel Sayer 📎 jhltonline.org/article/S1053-…


Is PYP ready for prime time for generalized screening for cardiac amyloidosis? An interesting debate of Pro Vs Con and overall perspective journalofnuclearcardiology.org/article/S1071-… Mallika Lal Ahmad Masri Adam Ioannou marianna fontana mathew.maurer Journal of Nuclear Cardiology


Current state of TR evaluation, management and direction of potential interventions in patients with LVADs Can transcather therapies help alleviate late RVF in select candidates? Now in JACC Journals, our review led by Boaz elad Gabriel Sayer Dan Burkhoff MD PhD RTHahnMD Dor Lotan, MD
